Esteve’s R&D&I has once again received the qualification ”Excellent” in the Profarma program Blog Post

Once again, Esteve‘s research activity has received the qualification ”Excellent” in the 2018 call of the Profarma program, resolved by the Spanish Ministry of Industry, Commerce and Tourism.The pharmaceutical group – that in 2012 established its key units for the discovery of drugs and preclinical development in the Barcelona Science Park– has been recognized with the highest rating for its commitment to innovation and quality of its research.

 

A study on autism done at IRB Barcelona in the running for the “Vanguardia de la Ciencia” Award Blog Post

For the fifth consecutive year, the Institute for Research in Biomedicine (IRB Barcelona) based in PCB has been nominated for the  “Vanguardia de la Ciencia” Award, thanks to research into autism, done in collaboration with the Centre for Molecular Biology “Severo Ochoa” (CBMSO), joint center between the Superior Council of Scientific Investigations (CSIC) and the Autonomous University of Madrid (UAM). The work in question established that the CPEB4 protein, which coordinates the expression of hundreds of genes necessary for neuronal activity, is altered in the brains of patients with this neurological disorder.

 

Europe looks to cells for a healthier future Blog Post

Researchers from the Centro Nacional de Análisis Genómico (CNAG-CRG) –based in the Barcelona Science Park and integrated into the Centre for Genomic Regulation (CRG) take part in the LifeTime consortium, which aims at understanding the constant changes within cells and their relationship to disease. The initiative will receive one million euros to devise a plan how to embed its vision into the European research and innovation landscape.

 

The PCB participates in a new edition of iFest: the festival of technology, science and disruptive innovation Blog Post

iFest, an event promoted by Catalunya Emprèn which brings young people closer to science, technology and disruptive innovation, is getting ready for a new edition, which will be preceded this year by a four-month learning and mentoring process, the iFest Countdown. During this programme, players will develop prototypes responding to real-life challenges proposed by various entities—including the Barcelona Science Park (PCB), the Institute for Bioengineering of Catalonia (IBEC) and the Institute of Biomedical Research (IRB Barcelona). In 2019’s iFest Zero, each team will have to defend their project and compete with other participants.

 

Tumor cell expansion challenges current physics Blog Post

The journal Nature Physics published a study by a team led by Xavier Trepat, ICREA researcher at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park and lecturer at the Department of Biomedicine University of Barcelona (UB), and Jaume Casademunt, professor of Physics at the UB, reveals the forces these tumor cells use to spread. The relation between these forces and the cell movement goes beyond current physical laws. 

 

Barcelona Science Park celebrates 20 years as a scientific and business innovation centre Blog Post

Yesterday, Barcelona Science Park (Parc Científic de Barcelona, PCB) held the first of a number of events scheduled to commemorate its 20 years as a meeting place for universities, companies and society. Established by the University of Barcelona (UB) in 1997 with the mission of promoting formulas to enhance research excellence, knowledge transfer and entrepreneurship, it was the first science park in Spain. Twenty years after the first brick was laid, the Barcelona Science Park is now one of Europe’s leading science, technology and business innovation parks for life sciences. Covering an area of over 100,000 m2, it boasts a wide range of scientific and technological infrastructures and an innovative community made up of more than 100 public and private entities and 2,700 professionals

 

Genesis Ventures selects the NeuroHeal project by the UAB’s Neurosciences Institute for its first investment Blog Post

The Genesis Ventures fund—managed by the consultancy firm Genesis Biomed headquartered in the Barcelona Science Park—has secured its first deal with its investment of €75,000 in the NeuroHeal project, a new pharmacological combination that accelerates nerve regeneration, developed at the Neurosciences Institute (INc) of the Autonomous University of Barcelona (UAB). 

 

Scientific and Technological Centers UB: 30 years of technology serving research and innovation Blog Post

The Scientific and Technological Centers of the University of Barcelona (CCiTUB) reached their first thirty years of activity over which they have become widely known in both the national and international fields of research, innovation, and transfer. At the moment, the team in CCiTUB is formed by a hundred and sixty experts and administration staff, and eighty of tem are doctors, distributed in thirty-eight units, six of which are located in the Barcelona Science Park (PCB), among which there is the Nuclear Magnetic Resonance Laboratory (LRB), listed in the Map of Unique Scientific and Technical Infraestructures (ICTS). 

 

GalChimia opens an R&D centre in the Barcelona Science Park Blog Post

Galician company GalChimia –a specialist in organic chemistry products and services for the pharmaceutical industry– has today opened its R&D centre in the Barcelona Science Park to step up its growth and internationalisation strategy. With this first subsidiary the Galicia-based company expects to increase its turnover by 25% over the next two years and step up its growth and internationalisation plan.